Review Article
Volume 9 Issue 4 - 2021
“Pharmacological Action and Clinical Use of the Drug Ceraxon (Citicoline): A Review of Experimental Data and Clinical Studies
ME Sergienko*
Road Clinical Hospital at St. Chelyabinsk Russian Railways JSC, Chelyabinsk, Russia
*Corresponding Author: ME Sergienko, Road Clinical Hospital at St. Chelyabinsk Russian Railways JSC, Chelyabinsk, Russia.
Received: April 01, 2020; Published: March 31, 2021




Abstract

Cytidine 5-diphosphocholine (CDP-choline, or citicoline) is an indispensable intermediate in the biosynthesis of structural phospholipids in cell membranes, in particular phosphatidylcholine. The review is dedicated to the study of citicoline (Ceraxon). The experimental data on its effect on traumatic injury and experimental cerebral edema, as well as the results of clinical use in traumatic brain injury and its consequences, are highlighted.

Keywords: Citicoline; Acetylcholine; Traumatic Brain Injury; Cerebral Edema; Post-Traumatic Memory Impairment

References

  1. Grieb P. “Neuroprotective properties of citicoline: facts, doubts and undersolved issues”. CNS Drugs 28 (2014): 185-193. 
  2. Martinez M., et al. “Some chemical aspects of human brain development II Phosphoglictride fatty acids”. Pediatric Research 8 (1974): 93-102.
  3. González-Padrones T and Rodríguez-Fernández C. “Los fosfolipidos como indice de maduracion cerebral”. Revista Clínica Española 167 (1982): 99-101.
  4. Padmini S and Srinivasa Rao P. “UPD galactos: ceramide galactosyltransferase, CDF choline in maijor regions of the developing rat brain in nutritional stress”. Neuroscience Research 23 (1989): 310-315.
  5. Bramanti V., et al. “Effects of choline-containing phospholipids on transglutaminase activity in primary astroglial cell cultures”. Clinical and Experimental Hypertension 30 (2008): 798-807. 
  6. Paoletti L., et al. “Lisophosphatidilcholine drives neuroblast cell fate”. Molecular Neurobiology 53.9 (2016): 6316-6331. 
  7. Lozano R. “La membrane neuronal: implicaciones terapeuticas”. Boletin de Neurology 2 (1993): 3-8.
  8. McMurray WC and Magee WL. “Phospholipid metabolism”. Annual Review of Biochemistry 41 (1972): 129-161.
  9. Nilsson B. “CDP-choline: a shot review. Drug treatment and prevention in cerebrovascular disorders”. Amsterdam: Elsvier/North Holland Biomedical Press (1979): 273-277.
  10. Agut J. “Neurotransmissores y membrane neuronal”. Revista Española de Geriatría y Gerontología 24 (1989): 16-21.
  11. Albergina M and Giuffrida-Stella AM. “Changes of phospholipid metabolizing and lysosomal enzymes in hypoglossal nucleus and ventral horn motoneurons during regeneration of craniospinal nerves”. Journal of Neurochemistry 51 (1988): 15-20.
  12. Boismare F. “Souffrance cerebraile: cjmportment et neurotransmetteurs sur des modeles experimentaux” (1980).
  13. Hayaishi O., et al. “Biochemical studies of head injury and brain edema”. Japanese Journal of Medicine 48 (1961): 519-539.
  14. Homayoun P., et al. “Cortical impact injury in rats promoters a rapid and sustained increase in polyunsaturated free fatty acids and diacylgiycerols”. Neurochemical Research 25 (2000): 269-276.
  15. De la Morena E., et al. “Citidindifosfato de cjlina y biosintes de fosfolipidos”. Barselona: Salvat (1985): 25-38.
  16. Vance DE and Pelech SL. “Cellular translocation of CTP: phosphocholine cytydyltransferase regulates the synthesis of CDP choline. Amsterdam: Elsevier Science Publishing (1985): 15-24.
  17. Tayebati SK and Amenta F. “Choline-containing phospholipids: relevance to brain functional pathways”. Clinical Chemistry and Laboratory Medicine 51 (2013): 513-521. 
  18. Dobolyi A., et al. “Uridine function in the central nervous system”. Current Topics in Medicinal Chemistry 11 (2011): 1058-1067.
  19. Horrocks LA and Dorman RV. “Prevention by CDP-choline and CDP-ethanolamine of lipid changes during brain ischemia. Amsterdam: Elsevier Science Publishing (1985): 205-215.
  20. Arrigoni E., et al. “Effects of CDP-choline on phospholipase A2 and choline phosphotransferase activities following a cryogenic brain injury in the rabbit”. Biochemical Pharmacology 36 (1987): 3697-3700.
  21. Freysz L., et al. “Metabolism of neuronal cell culture: Modifications induced by CDP-choline. Novel biochemical, pharmacological and clinical aspects CDP-choline Amsterdam: Elsevier Science Publishing (1985): 117-125.
  22. Algate DR., et al. “Study on the effects of oral administration CDP-choline on EEG changes and lethality induced by epidural compression in the anesthetized cat”. Arzneimittelforschung 33.2 (1983): 1013-1016. 
  23. Hayaishi O., et al. “Biochemical studies of head injury and brain edema”. Japanese Journal of Medicine 48 (1961): 519-539.
  24. Kondo Y. “Experimental study of the therapeutic use of cytidine nucleotids for brain injury”. Nihon Geka Hokan 32 (1964): 489-505.
  25. Boismare F., et al. “Etude des effets de la administration de cytidinediphosphocholine sur les consequences hemodynamiques, fonctionelles, et biochimiques du traumatisme cranioctrvical chez le rat”. Therapie 32 (1977): 345-354.
  26. Dixon CE., et al. “Effects of CDP-choline treatment on neurobehavioral deficits after TBI and on hippocampal and neocortical acetylcholine release”. Journal of Neurotrauma 14 (1997): 161-169.
  27. Başkaya MK., et al. “Neuroprotective effects of citicoline on brain edema and blood-brain barrier breakdown after traumatic brain injury”. Journal of Neurosurgery 92 (2000): 448-452.
  28. Cakir E., et al. “Effects of citicoline on experimental spinal cord injury”. Journal of Clinical Neuroscience 12 (2005): 924-927.
  29. Wang L., et al. “Most effective adjuvant treatments after surgery in peripheral nerve laceration: systematic review of the literature on rodent models”. Restorative Neurology and Neuroscience 31 (2013): 253-262. 
  30. Levin HS. “Treatment of postconcussional symptoms with CDP-choline”. Journal of the Neurological Sciences 103 (1991): 39-42.
  31. Anniruddha TJ., et al. “Role of citicoline in the management of mild head injury”. Indian Journal of Neurotrauma 6 (2009): 49-52. 
  32. Leon-Carrion J., et al. “Advances in the treatment of memory deficits after citicholine”. 3rd World Congress on Brain Injury. Quebec (1999). 
  33. Leon-Carrion J., et al. “Normalization of memory-related cerebral blood flow in severe traumatic brain injury patients and improvements of memory induced by citicholine (CDP-choline): the role of a pro-cogntive drug”. ICRAN 99. Taiwan (1999).
  34. León-Carrión J., et al. “The role of citicholine in neuropsycholjgical training after traumatic brain injury”. Neurorehabilitation 14 (2000): 33-40.
  35. Wortzel HS and Arciniegas DB. “Treatment of post-traumatic cognitive impairments are”. Current Treatment Options in Neurology 14 (2012): 493-508. 
  36. Spiers PA and Hochanadel G. “Citicoline for traumatic brain injury: report of two cases, including my own”. Journal of the International Neuropsychological Society 5 (1999): 260-264.
  37. Chinnock P and Pokkunuri V. “CDP-choline for acute traumatic brain injury”. Cochrane Database of Systematic Reviews 3 (2005): CD005402.
  38. Zafonte R., et al. “The citicoline brain injury treatment (COBRIT) trial: design and methods”. Journal of Neurotrauma 26 (2009): 2207-2216. 
  39. Zafonte RD., et al. “Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT)”. The Journal of the American Medical Association 308 (2012): 1993-2000. 
  40. Secades JJ. “Citicoline for the treatment of head injury: a systematic review and meta-analysis of controlled clinical trials”. Journal of Trauma and Treatment 4 (2014): 227.
  41. I Sayed., et al. “A meta-analysis of the different neuroprotective drugs in management of patients with traumatic brain injury”. Revista de Neurología 41.2 (2018): 427-438. 
  42. El Reweny EM., et al. “The neuroprotective effect of citicoline in patients with traumatic S68”. Revista de Neurología (2017). 
  43. Salehpour F., et al. “Neuroprotective effects of citicoline in diffuse axonal injuries”. Advances in Bioscience and Clinical Medicine 1 (2013): 12-15.
Citation: ME Sergienko. “Pharmacological Action and Clinical Use of the Drug Ceraxon (Citicoline): A Review of Experimental Data and Clinical Studies”. EC Pharmacology and Toxicology 9.4 (2021): 80-86.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


April Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the April issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before May 04, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk